PL3728215T3 - Jednonaczyniowy sposób wytwarzania racemicznej nikotyny w reakcji nikotynianu etylu z n-winylopirolidonem w obecności etanolanu sodu lub etanolanu potasu lub ich mieszanin - Google Patents

Jednonaczyniowy sposób wytwarzania racemicznej nikotyny w reakcji nikotynianu etylu z n-winylopirolidonem w obecności etanolanu sodu lub etanolanu potasu lub ich mieszanin

Info

Publication number
PL3728215T3
PL3728215T3 PL18816110T PL18816110T PL3728215T3 PL 3728215 T3 PL3728215 T3 PL 3728215T3 PL 18816110 T PL18816110 T PL 18816110T PL 18816110 T PL18816110 T PL 18816110T PL 3728215 T3 PL3728215 T3 PL 3728215T3
Authority
PL
Poland
Prior art keywords
ethanolate
vinylpyrrolidone
mixtures
reaction
preparation
Prior art date
Application number
PL18816110T
Other languages
English (en)
Inventor
Beat Weber
Christian LOTHSCHÜTZ
Ben PAN
Original Assignee
Siegfried Ag
Contraf-Nicotex-Tobacco Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Ag, Contraf-Nicotex-Tobacco Gmbh filed Critical Siegfried Ag
Publication of PL3728215T3 publication Critical patent/PL3728215T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Addiction (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL18816110T 2017-12-22 2018-12-18 Jednonaczyniowy sposób wytwarzania racemicznej nikotyny w reakcji nikotynianu etylu z n-winylopirolidonem w obecności etanolanu sodu lub etanolanu potasu lub ich mieszanin PL3728215T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17210187 2017-12-22
EP18816110.3A EP3728215B1 (en) 2017-12-22 2018-12-18 One-pot process for the preparation of racemic nicotine by reaction of ethyl nicotinate with n-vinylpyrrolidone in the presence of sodium ethanolate or potassium ethanolate or mixtures thereof
PCT/EP2018/085437 WO2019121644A1 (en) 2017-12-22 2018-12-18 Preparation of racemic nicotine by reaction of ethyl nicotinate with n-vinylpyrrolidone in the presence of an alcoholate base and subsequent process steps

Publications (1)

Publication Number Publication Date
PL3728215T3 true PL3728215T3 (pl) 2022-05-16

Family

ID=60782090

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18816110T PL3728215T3 (pl) 2017-12-22 2018-12-18 Jednonaczyniowy sposób wytwarzania racemicznej nikotyny w reakcji nikotynianu etylu z n-winylopirolidonem w obecności etanolanu sodu lub etanolanu potasu lub ich mieszanin

Country Status (25)

Country Link
US (1) US11407730B2 (pl)
EP (1) EP3728215B1 (pl)
JP (1) JP7085641B2 (pl)
KR (1) KR102575964B1 (pl)
CN (1) CN111511726A (pl)
AU (1) AU2018391652B2 (pl)
BR (1) BR112020012457A2 (pl)
CA (1) CA3085245C (pl)
CL (1) CL2020001657A1 (pl)
CY (1) CY1124741T1 (pl)
DK (1) DK3728215T3 (pl)
ES (1) ES2898315T3 (pl)
HR (1) HRP20211777T1 (pl)
HU (1) HUE057748T2 (pl)
IL (1) IL275584B2 (pl)
LT (1) LT3728215T (pl)
MY (1) MY201265A (pl)
PE (1) PE20211237A1 (pl)
PL (1) PL3728215T3 (pl)
PT (1) PT3728215T (pl)
RS (1) RS62759B1 (pl)
RU (1) RU2753548C1 (pl)
SG (1) SG11202005639UA (pl)
SI (1) SI3728215T1 (pl)
WO (1) WO2019121644A1 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3710437T3 (da) 2017-12-22 2023-02-20 Siegfried Ag Enantiomerseparation af racemisk nicotin ved tilsætning af en o,o'-disubstitueret vinsyreenantiomer med lav optisk renhed
CN110256403B (zh) * 2019-07-02 2020-06-19 深圳市馨艺坊生物科技有限公司 一种人工合成尼古丁的制备方法
WO2021127986A1 (zh) * 2019-12-24 2021-07-01 深圳雾芯科技有限公司 一种制备尼古丁的方法
CN112125883A (zh) * 2020-10-22 2020-12-25 东莞市鸿馥生物科技有限公司 一种消旋烟碱的合成方法
CN114437025B (zh) * 2020-11-05 2023-08-25 上海零诺生物科技有限公司 消旋6-甲基烟碱及其制备方法、以及应用
CN112409327A (zh) * 2020-11-18 2021-02-26 山东金城医药化工有限公司 一种高光学纯度烟碱的制备方法
CN112795603B (zh) * 2020-12-14 2022-06-24 山东金城医药化工有限公司 一种制备(s)-2-(3-吡啶)-吡咯烷的方法
CN113087697A (zh) * 2021-04-12 2021-07-09 深圳市优绿信生物科技有限公司 一种尼古丁的合成方法
CN114702474B (zh) * 2021-04-21 2023-03-28 黄冈中有生物科技有限公司 一种左旋烟碱的制备方法
CN114644614B (zh) * 2021-04-21 2023-03-28 黄冈中有生物科技有限公司 一种左旋烟碱的制备方法
CN115260088A (zh) * 2021-04-30 2022-11-01 武汉中有药业有限公司 烟碱及其中间体的制备方法
CN113475740B (zh) * 2021-07-10 2022-10-21 深圳市真味生物科技有限公司 一种手性合成尼古丁的制备方法
CN113475739B (zh) * 2021-07-10 2022-11-11 深圳市真味生物科技有限公司 一种s-尼古丁的制备方法
CN113416180A (zh) * 2021-08-09 2021-09-21 东莞市鸿馥生物科技有限公司 一种(s)-1-甲基-2-(3-吡啶基)吡咯烷的拆分方法
CN114195759B (zh) * 2021-08-26 2023-10-20 上海零诺生物科技有限公司 一种2-甲基-5-(1-甲基吡咯烷-2-基)吡啶制备方法
CN113788815A (zh) * 2021-09-27 2021-12-14 成昌梅 一种烟碱中间体的合成制备方法
CN113999201B (zh) * 2021-11-03 2023-11-03 成昌梅 一种烟碱的合成制备方法
CA3238151A1 (en) 2021-11-15 2023-05-19 Shahin ROOHINEJAD Oral products with nicotine-polymer complex
CN114989135A (zh) * 2022-01-19 2022-09-02 广州天然科技有限公司 一种2-甲基-5-(1-甲基吡咯烷-2-基)吡啶的有机酸盐及其制备方法
CN114671852A (zh) * 2022-04-24 2022-06-28 仙居两山生物科技有限公司 一种高纯度左旋烟碱医药中间体的制备方法
CN115093394B (zh) * 2022-07-20 2024-10-18 北京世桥生物制药有限公司 S-(-)-尼古丁(-)-二苯甲酰-l-酒石酸盐晶型、制备方法及应用
EP4332098A1 (en) 2022-08-31 2024-03-06 Siegfried AG Chiral synthesis of nornicotine and nicotine
EP4601490A1 (en) 2022-10-14 2025-08-20 Nicoventures Trading Limited Capsule-containing pouched products
CN115594662A (zh) * 2022-10-19 2023-01-13 昆明理工大学(Cn) 一种(s)-烟碱的制备方法
WO2024095163A1 (en) 2022-11-01 2024-05-10 Nicoventures Trading Limited Oral composition comprising encapsulated ph adjusting agent
GB202319624D0 (en) 2023-12-20 2024-01-31 Nicoventures Trading Ltd Functionalized fleece for oral products
GB202319617D0 (en) 2023-12-20 2024-01-31 Nicoventures Trading Ltd Elastic fleece for oral products
GB202319623D0 (en) 2023-12-20 2024-01-31 Nicoventures Trading Ltd Biodegradable fleece for oral product
EP4659594A1 (en) 2024-06-06 2025-12-10 Nicoventures Trading Limited Oral products containing modified nicotine-polymer complex
EP4659595A1 (en) 2024-06-06 2025-12-10 Nicoventures Trading Limited Nicotine-polymer complex comprising multiple nicotine forms
EP4659596A1 (en) 2024-06-06 2025-12-10 Nicoventures Trading Limited Oral products with low free-base nicotine content

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3219946B2 (ja) 1994-09-22 2001-10-15 大鵬薬品工業株式会社 新規製造中間体及びピリジン誘導体の製造方法
JP2003342259A (ja) 2001-12-21 2003-12-03 Toray Ind Inc 光学活性シスピペリジン誘導体の製造法
AU2003265395A1 (en) 2002-08-14 2004-03-03 Ppd Discovery, Inc. Prenylation inhibitors and methods of their synthesis and use
JP2006335639A (ja) 2003-01-23 2006-12-14 Nagase & Co Ltd 光学活性なフルルビプロフェンの製造方法
CN102617547B (zh) 2011-01-27 2016-02-10 上海特化医药科技有限公司 一种制备消旋尼古丁的方法
US8378111B2 (en) 2011-02-02 2013-02-19 Divi's Laboratories, Ltd. Process for the resolution of (R,S)-nicotine
US8367837B2 (en) * 2011-02-14 2013-02-05 Divi's Laboratories, Ltd. Process for the preparation of (R,S)-nicotine
US10943111B2 (en) 2014-09-29 2021-03-09 Sony Interactive Entertainment Inc. Method and apparatus for recognition and matching of objects depicted in images
WO2016061751A1 (en) 2014-10-22 2016-04-28 Merck Sharp & Dohme Corp. Ethyl n-boc piperidinyl pyrazolo pyridones as janus kinase inhibitors
EP3209653B1 (en) 2014-10-22 2021-06-09 Next Generation Labs, LLC Process for the preparation of (r,s)-nicotine
US9809567B2 (en) * 2014-12-09 2017-11-07 Njoy, Llc Synthesis and resolution of nicotine
AU2016381372B2 (en) 2015-12-30 2021-07-22 Next Generation Labs, LLC Nicotine replacement therapy products comprising synthetic nicotine
EP3400219B1 (en) 2016-01-08 2020-03-25 Council of Scientific and Industrial Research A process for the preparation of nicotine
DK3710437T3 (da) 2017-12-22 2023-02-20 Siegfried Ag Enantiomerseparation af racemisk nicotin ved tilsætning af en o,o'-disubstitueret vinsyreenantiomer med lav optisk renhed

Also Published As

Publication number Publication date
HRP20211777T1 (hr) 2022-03-04
HUE057748T2 (hu) 2022-06-28
AU2018391652B2 (en) 2022-03-10
SI3728215T1 (sl) 2022-01-31
US11407730B2 (en) 2022-08-09
PE20211237A1 (es) 2021-07-09
CA3085245A1 (en) 2019-06-27
EP3728215B1 (en) 2021-10-13
CL2020001657A1 (es) 2020-11-13
JP7085641B2 (ja) 2022-06-16
CN111511726A (zh) 2020-08-07
BR112020012457A2 (pt) 2020-11-24
AU2018391652A1 (en) 2020-07-02
CY1124741T1 (el) 2022-07-22
US20200331884A1 (en) 2020-10-22
IL275584B1 (en) 2023-04-01
PT3728215T (pt) 2021-11-22
RS62759B1 (sr) 2022-01-31
ES2898315T3 (es) 2022-03-07
CA3085245C (en) 2023-06-13
KR102575964B1 (ko) 2023-09-06
RU2753548C1 (ru) 2021-08-17
MY201265A (en) 2024-02-14
EP3728215A1 (en) 2020-10-28
WO2019121644A1 (en) 2019-06-27
IL275584B2 (en) 2023-08-01
LT3728215T (lt) 2021-12-10
JP2021517901A (ja) 2021-07-29
DK3728215T3 (da) 2021-11-08
KR20200103033A (ko) 2020-09-01
IL275584A (en) 2020-08-31
SG11202005639UA (en) 2020-07-29

Similar Documents

Publication Publication Date Title
HUE057748T2 (hu) Egyedényes eljárás racém nikotin elõállítására, etil-nikotinát vinilpirrolidonnal végzett reakciójával, nátrium-etanolát vagy kálium-etanolát vagy ezek keverékeinek jelenlétében
EP3294865A4 (en) PROCESS FOR THE PREPARATION OF EPIMERASES AND BENZYLISOCHINOLINAL KALOIDES
EP3443094A4 (en) PROCESS FOR REDUCING C9ORF72 EXPRESSION
EP3320008C0 (en) NOVEL URETHANE-BASED MATERIALS, DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND USES
EP3395952A4 (en) COMPOSITION FOR THE PREPARATION OF D-PSICOSE WITH D-PSICOSE-3 EPIMERASE AND SALT AND METHOD FOR THE PRODUCTION OF D-PSICOSE USING THEREOF
IL271974A (en) New intermediates useful for the synthesis of aminopyrimidine derivatives, a process for their preparation and a process for preparing aminopyrimidine derivatives using them
EP3310358A4 (en) COMPOSITIONS AND METHODS FOR TREATING SUBSTANCE ABUSE, SEARCH AND PSYCHIATRIC DISORDER
EP3428158A4 (en) SALT OF PYRIDINYL-AMINO-PYRIMIDINE DERIVATIVE, METHOD OF MANUFACTURING THEREOF AND THE APPLICATION THEREOF
IL287119A (en) Bryostatin compounds and methods for their preparation
EP3265455A4 (en) CHEMICAL PROCESS FOR THE PREPARATION OF PYRIMIDINE DERIVATIVES AND INTERMEDIATE PRODUCTS THEREOF
ZA201903769B (en) L-valinate of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
SG11201506409RA (en) Crystals of laquinimod sodium and improved process for the manufacture thereof
GB2555748B (en) Novel form of isoxadifen-ethyl, process for preparation and use thereof
EP3277098A4 (en) Novel and useful edible salt and methods of use and production thereof
PL2965639T3 (pl) Jednostka przyłącza do elementów artykułów dla palaczy
IL246835A0 (en) Improved process for the preparation of trazodone and its hydrochloride salt
EP3353149A4 (en) PROCESS FOR THE PREPARATION OF INDOLIN COMPOUNDS AND A NOVEL INDOLIN SALT
MA40585A (fr) Sel de dérivé de céphalosporine, forme solide cristalline de celui-ci et son procédé de production
IL267227A (en) Methods of administering hepcidin
GB2559718B (en) Novel crystalline form of tribenuron-methyl, process for preparation and use thereof
GB2564185B (en) Process for the preparation of derivatives of benzodioxole
PL3347309T3 (pl) Sposoby wytwarzania soli srebra(ii) i ich hydratów, produkty otrzymane tymi sposobami i ich zastosowanie do modyfikacji struktury cząsteczek związków organicznych
KR102150179B9 (ko) 나트륨 시아나이드의 제조 방법
IL259332A (en) Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives
GB201809834D0 (en) Novel crystalline form of the thifensulfuron-methyl, process for preparation and use thereof